Učitavanje...

Development of therapeutic antibodies for the treatment of diseases

It has been more than three decades since the first monoclonal antibody was approved by the United States Food and Drug Administration (US FDA) in 1986, and during this time, antibody engineering has dramatically evolved. Current antibody drugs have increasingly fewer adverse effects due to their hi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Biomed Sci
Glavni autori: Lu, Ruei-Min, Hwang, Yu-Chyi, Liu, I-Ju, Lee, Chi-Chiu, Tsai, Han-Zen, Li, Hsin-Jung, Wu, Han-Chung
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6939334/
https://ncbi.nlm.nih.gov/pubmed/31894001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-019-0592-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!